Zorayr Manukyan, Ph.D Leadership Team Member

Dr. Manukyan is an experienced leader with over 20 years of experience in the healthcare industry with a broad combination of skills, multi-disciplinary knowledge and regulatory experience. He has been highly successful in building cutting-edge technology and service companies in healthcare after holding leadership positions in Biotechnology (Pfizer, Biogen, Merck, Emmes Corporation). Dr. Manukyan holds double doctoral degrees in Statistics and Biology, along with an MS (ABD) in Computational Mathematics and an MS in Industrial Mathematics, with a concentration in Biotechnology. His contributions to the field are evident in his authorship of over 35 publications. In addition, he serves as an Advisory Board Member for the Department of Statistics at George Mason University. Dr. Manukyan brings strategic vision and leadership in healthcare technology and clinical research. His track record includes participation in numerous successful regulatory submissions to the FDA and EMA, spanning various therapeutic areas including diagnostic systems, oncology, rare diseases, immunoscience, pediatrics, and transfusion medicine.

Vahan Simonyan, Ph.D Leadership Team Member

Dr. Simonyan accomplishments in academic and R&D technology carriers have been complemented with the success in authorship and technology leadership roles in government (NIH, NCBI, FDA), academia, and industry to establish large-scale and complex, science-heavy R&D infrastructures capable of serving worldwide communities for research and regulatory purposes: PubChem, CDD, SRA, FDA-HIVE, IEEE-BioCompute. The expertise includes health-IT and biomedical informatics: data archival, and analytics in clinical, genomic, and real-world evidence domains; infrastructure support for registries on cancer, autoimmune diseases, rare diseases, robotics, medical devices; standardization, harmonization, standards and ontology development; digital health policy in national and international arena for data privacy; R&D in artificial intelligence and modern bioinformatics approaches to support healthcare domains.

Nadia Abu Hijleh, Leadership Team Member

Co-Founder and Innovator in Laboratory Technologies and Healthcare Solutions
Dr. Abu Hidjleh is the co-founder of eight pioneering companies in the technology and laboratory sectors, including Neoscience Group (UAE and Kenya), Qatar Scientific Company, and Gulf Scientific Company, with multiple subsidiary ventures across the Middle East. Through these ventures, she has continuously pushed the boundaries of innovation in science and healthcare, reshaping the laboratory business landscape by leveraging advancements in Genomics, OMICS, and Artificial Intelligence (AI) to drive the future of healthcare.

Under Dr. Abu Hidjleh’s leadership, these companies provide tailored solutions to over 350 customers, supported by a robust portfolio of more than 59 business partners in diagnostics, genomics, OMICS, and AI. This strategic approach is designed to meet the growing demand for innovative healthcare solutions, fueling the next wave of growth in life sciences.

Dr. Abu Hidjleh is a strong advocate of AI and OMICS as key drivers of disruptive growth in healthcare, recognizing AI as the largest total addressable market (TAM) within life sciences. In collaboration with ClinStatDevice, Nadia Abu Hidjleh and the team are advancing clinical trials and cancer insights, focusing on areas such as precision medicine, cell and gene therapy, NGS-based companion diagnostics, pathogen diagnostics, medical device technologies, vaccine development, and treatments for oncological and rare diseases.

Raja Mazumder, Ph.D Scientific Advisor

Dr. Raja Mazumder has extensive experience in biocuration and annotation and was one of the original architects of BioCompute. He has successfully led several bioinformatics projects, including the development and deployment of a cancer knowledgebase that facilitates digestible content from diverse data sources. Dr. Mazumder will have executive oversight of all GW activities and will lead the integration of all annotation activities. He will also help to develop the LOT – including the generation of a data dictionary as needed – and will coordinate human and computer resources for the project at GW.